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SUMMARY
Type II 3b-hydroxysteroid dehydrogenase/D5-D4-isomerase (3b-HSD2), encoded by the HSD3B2 
gene, is a key enzyme involved in the biosynthesis of all the classes of steroid hormones. De-
leterious mutations in the HSD3B2 gene cause the classical deficiency of 3b-HSD2, which is a 
rare autosomal recessive disease that leads to congenital adrenal hyperplasia (CAH). CAH is 
the most frequent cause of ambiguous genitalia and adrenal insufficiency in newborn infants 
with variable degrees of salt losing. Here we report the molecular and structural analysis of the 
HSD3B2 gene in a 46,XY child, who was born from consanguineous parents, and presented with 
ambiguous genitalia and salt losing. The patient carries a homozygous nucleotide c.665C>A 
change in exon 4 that putatively substitutes the proline at codon 222 for glutamine. Molecular 
homology modeling of normal and mutant 3b-HSD2 enzymes emphasizes codon 222 as an im-
portant residue for the folding pattern of the enzyme and validates a suitable model for analysis 
of new mutations. Arq Bras Endocrinol Metab. 2010;54(8):768-74
SUMÁRIO
A enzima 3b-hydroxysteroid dehydrogenase/D5-D4-isomerase do tipo 2 (3b-HSD2), codificada 
pelo gene HSD3B2, é importante na biossíntese de todas as classes de hormônios esteroides. 
As mutações no gene HSD3B2 podem causar deficiência da 3b-HSD2 da forma clássica. É de he-
rança autossômica recessiva e uma das causas mais raras de hiperplasia congênita da adrenal 
(HCA). A deficiência dessa enzima leva frequentemente à ambiguidade genital e à insuficiência 
da adrenal em recém-nascidos com vários níveis de perda de sal. Neste trabalho, foi feito o 
estudo estrutural e molecular do gene HSD3B2 gene em um paciente 46,XY, filho de pais con-
sanguíneos, com ambiguidade genital e perda de sal. O paciente é homozigoto para a troca nu-
cleotídica c.665C>A no éxon 4, que putativamente leva à substituição de uma prolina do códon 
222 por uma glutamina. A modelagem molecular por homologia das enzimas 3b-HSD2 normal 
e mutantes ressaltou que a prolina no códon 222 é um resíduo importante no enovelamento 
da enzima e validou um modelo adequado para avaliações de novas mutações. Arq Bras Endocrinol 
Metab. 2010;54(8):768-74
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INTRODUCTION
The steroidogenic enzyme 3b-hydroxysteroid dehy-drogenase/D5-D4-isomerase (3b-HSD) is a mem-
brane-bound NADH-dependent enzyme involved in 
the biosynthesis of all the classes of steroid hormones, 
namely glucocorticoids, mineralocorticoids, proges-
terone, androgens, and estrogens (1). Those steroid 
hormones play an important role in processes such as 
differentiation, development, and growth and in physio-
logical functions in the most human tissues (2).
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The dehydroepiandrosterone (DHEA) is used as 
substrate in a two-step reaction catalyzed by 3b-HSD. 
During the reaction, the reduction of NAD+ to NADH 
occurs by a rate-limiting activity of 3b-HSD followed 
by the NADH recruitment for the activation of isom-
erase activity on the same enzyme. A previous model 
of the type 1 enzyme suggests that both 3b-HSD and 
isomerase domains of the enzyme are linked by a shared 
coenzyme domain that may function as both binding 
site domain for NAD+ during the 3b-HSD reaction and 
as coenzyme domain for the allosteric activation for 
isomerase activity (3).
In humans, there are two types of 3b-HSD isoen-
zymes encoded by two genes that are very similar in 
structure and both are located on 1p13.1 (2,4,5). Type 
I gene (HSD3B1) is expressed in placenta and peripher-
al tissues. Type II gene (HSD3B2) encodes the adrenal 
and gonadal 3b-HSD enzymes (5,6). In the adrenal, 
type II 3b-HSD is a key enzyme required for the pro-
duction of cortisol and aldosterone (7).
Deleterious mutations in the HSD3B2 gene cause 
classical 3b-HSD2 deficiency (OMIM # +201810), 
which is an autosomal recessive inherited form of con-
genital adrenal hyperplasia (CAH) that impairs steroido-
genesis in both the adrenals and gonads (8-11). The 
clinical manifestation of classical 3b-HSD2 deficiency 
ranges from salt-losing to non salt-losing forms in both 
sexes. In newborns, 3b-HSD2 deficiency results in am-
biguity of the external genitalia in genetic males, while 
affected females exhibit normal sexual differentiation or 
partial virilization. During adolescence, 3b-HSD2 de-
ficiency results in variable degrees of hypogonadism in 
boys and hyperandrogenism (premature pubarche and 
hirsutism) in girls. The nonclassical form of 3b-HSD2 
deficiency has been described in females with hyperan-
drogenism, but no HSD3B2 mutations were found in 
those patients (12-18).
In the present study we describe the clinical and 
molecular characterization of a patient diagnosed as 
having the classical form of congenital adrenal hyper-
plasia (CAH) due to 3b-HSD2 deficiency. Molecular 
analysis of the HSD3B2 gene revealed the homozygous 
c.665C>A missense mutation in codon 222 changing 
the proline to glutamine. Molecular homology model-
ing of 3b-HSD2 was performed. We used sequences of 
three-dimensional structure determined by X-ray crys-
tallography that showed 30% identity with the protein 
sequence of 3b-HSD2. The proposed model empha-
sizes the critical importance of the P222 residue on the 
overall 3b-HSD2 enzyme integrity and activity.
CASE REPORT
The patient is a Caucasian male child born at term af-
ter an uneventful pregnancy from a consanguineous 
marriage. At birth he weighed 3.2 kg and his height 
was 50 cm. He was referred to us for investigation 
of ambiguous genitalia. In the first evaluation, at 23 
days of life, his height was 50 cm, weight was 2.85 
kg; he had a 3 cm-long phallus and complete fusion 
of the labioscrotal folds with only one palpable gonad. 
His karyotype was 46,XY. He had high serum levels 
of 17OHProgesterone (942 ng/mL – 28.5 nmol/L) 
with normal dosages of sodium (137 mEq/L) and po-
tassium (6.0 mEq/L). Thus, diagnosis of CAH was 
suspected. Despite dexamethasone treatment he pre-
sented poor weight gain with a hyponatremic (129 
mEq/L) dehydration episode associated with hyper-
kalemia (7.6 mEq/L) at 2 months of age. Laboratory 
investigation showed a DHEA/D4-DIONE ratio of 
17.5. Diagnosis of CAH due to 3b-HSD deficiency 
was considered. Thereafter, therapy with glucocorti-
coid (hydrocortisone) and mineralocorticoid (fludro-
cortisone) replacement was established leading to gain 
of weight and normal growth rate. 
This study was approved by the appropriate Ethics 
Committee from the State University of Campinas (São 
Paulo, Brazil) and informed consents were obtained 
from the patient and his parents. 
METHODS
Genomic DNA was isolated from blood leukocytes 
using standard techniques. Primers and conditions 
for PCR amplification of the entire coding region of 
the HSD3B2 gene were based on a published report 
(6). Purified PCR products were sequenced in both 
sense and antisense orientations using ABI PRISM 
377 Automated DNA Sequencer according to the 
manufacturer’s recommendations (Applied Biosys-
tems, USA).
The three-dimensional structure of both mutant 
and native 3b-HSD2 proteins were modeled using the 
crystal structure of Vestitone Reductase from Medicago 
sativa L. (Protein Data Bank accession number 2P4H) 
as a template (19). Models were created and validated 
by using default settings and parameters of the Swiss 
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Model web-served software. The modeled protein 
structures were produced and analyzed by using the 
web-based BlueStar STING software (20).
RESULTS 
DNA sequencing of the patient’s HSD3B2 gene re-
vealed the homozygous missense mutation p.P222Q 
(CCA>CAA). Both parents and his sister were found 
to be heterozygous for this mutation (Figure 1A). The 
nucleotide substitution was confirmed by at least three 
independent PCR and sequencing analyses, in both 
sense and antisense strands. Protein alignment showed 
that the proline at residue 222 is highly conserved 
among the mammalian 3b-HSD family, as demonstrat-
ed in figure 1B.
Structural studies were carried out with both 
p.P222Q and p.P222T mutations for comparison pur-
poses. Blast results for the native human 3b-hydroxys-
teroid dehydrogenase/D5-D4-isomerase showed the 
vestitone reductase from Medicago sativa L. (PDB-ID 
2P4H) as the most similar structure with a score of 
31%. Based on this sequence identity, a three-dimen-
sional ribbon model of human 3b-hydroxysteroid de-
hydrogenase/D5-D4-isomerase was constructed using 
the vestitone reductase sequence as template (Figure 
2A). The ribbon structures for both native and for the 
two different 3b-HSD2 mutants in residue 222 dem-
onstrated a prominent side-chain group for both gluta-
mine and threonine as compared to the native proline 
(Figure 2B and C). In addition, the analysis of internal 
contacts (Figure 2D, E, and F) showed that the native 
residue Pro222 makes a hydrogen-bond with Y254 in 
main chain and hydrophobic interactions with Y224, 
V220, and also with Y254. The mutated residues Gln222 
and Thr222 eliminate the hydrophobic interaction with 
Val220. In complement, T222 enzyme interacts with 
residue Y254 by establishing hydrogen-bonds with 
the main chain and side chains. The domain formed 
Figure 1. (A) Partial nucleotide sequence of exon 4 of the HSD3B2 gene showing the C>A transversion (black arrows) in both sense (left) and antisense 
(right) strands. Upper panels show patient’s sequence who is homozygous for the nucleotide change; lower panels show his sister’s sequence who is 
heterozygous. (B) Clustalw comparison of the partial amino acid sequences of mammalian 3b-HSD isoenzymes. Residue Pro222 is marked in red (red arrow). 
Amino acid residues are designated by single letter code and numbered according to the first NH2-terminal methionine of human 3b-HSD2. Conserved 
residues in 3b-HSD2 proteins are boxed in blue. 
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by residues 251-274, which is a region for substrate 
binding, demonstrates important structural modifica-
tions when P222 is replaced by Q222 or T222. Most 
remarkable is that the wild-type protein presents a flex-
ible turn while both mutant proteins show a b-sheet in 
this region (Figure 3). 
Structural aspects of HSD3B2 gene mutations
Figure 2. (A) Ribbon structure of native 3b-HSD2 (cyan), the P222 residue is denoted in red. (B) Aligned ribbon structure of both native and mutants 
3b-HSD2 demonstrating the prominent side-chain group of the mutant threonine (red) as compared to the side-chain group of proline (blue). (C) P222 on 
the native enzyme (blue) and Q222 mutant enzyme (green). STING report contacts obtained from the BlueStar STING software. The images show internal 
contacts of proline, glutamine, and threonine on the respective native (D), Q222 (E) and T222 (F) enzymes. Lines denote different interactions: hydrophobic 
interactions (magenta); hydrogen bond main chain-main chain (rose); hydrogen bond side chain-main chain (salmon). Bars below each amino acid are 
internal contacts in each amino acid. Bar color represents the contact type and its width represents the contact number. 
Figure 3. Overlap of wild-type structure of 3b-HSD2 (cyan) and the Q222 (magenta) and T222 (green) mutant proteins. Substrate binding domains are 
identified in different colors: wild-type (blue), Q222 (red), and T222 (green). In detail, region 251-274 substrate binding domain. 
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DISCUSSION
p.P222Q mutation has already been described as lead-
ing to a complete loss of 3b-HSD2 activity (21). The 
severe form of 3b-HSD2 deficiency in the homozy-
gous patient here reported confirms a good correlation 
genotype-phenotype for the mutation. These findings 
suggest that residue position 222 is important for en-
zymatic activity.
Two different missense mutations have been identi-
fied in codon 222, depending on the mutated nucleo-
tide being located in the first or in the second nucleo-
tide of the codon (21-23). The c.664C>A  transversion 
in the first nucleotide of codon 222 (CCA>ACA) leads 
to the replacement of a proline by a threonine. The mis-
sense mutation p.P222T has been identified in an East-
ern European female neonate with classic salt-losing 
disorder (23). Whereas, the transversion c.664C>A in 
the second nucleotide of codon 222 CCA>CAA con-
verts a proline to a glutamine. The missense mutation 
p.P222Q has been previously identified in two Algerian 
siblings (22). In the Brazilian population the p.P222Q 
mutation was found in two sisters in compound het-
erozygosis with the p.G129R mutation (24) and in a 
homozygous male patient with the salt-losing form of 
3b-HSD2 deficiency (25). The case described here is a 
Brazilian male with typical clinical features of classical 
3b-HSD2 deficiency who is also homozygous for the 
p.P222Q mutation. 
Both mutations on P222 residue abolished the 
3b-HSD2 activity as demonstrated by in vitro assays 
(22,23). The importance of this residue is evidenced 
by the fact that the residue is predicted to be within the 
membrane-spanning domain suggesting a putative role 
on the ultimate folding pattern of the enzyme (2). In 
addition, P222 residue is located adjacent to the sub-
strate-binding domain being highly conserved in that 
particular position (26). Although both p.P222Q and 
p.P222T mutations render the 3b-HSD2 enzyme with 
no detectable activity from the structural point of view, 
they probably do so due to different effects. Moisan 
and cols. (22) report that p.P222Q enzyme did not 
show any evidence of protein instability. They discuss 
that the absence of enzymatic activity was probably due 
to alterations in the catalytic activity of the enzyme, 
such as significant changes in the substrate-binding do-
main introduced by the presence of glutamine in codon 
222. On the other hand, p.P222T enzyme showed no 
detectable signal on Western blot despite mRNA pro-
duction, suggesting a totally unstable protein (23). It 
was considered that the severe instability of the enzyme 
was the main detrimental mechanism that profoundly 
decreased 3b-HSD2 activity (23). In order to obtain 
novel information concerning the structure-function 
relationship of 3b-HSD2 mutant enzymes we char-
acterized the functional significance of p.P222Q and 
p.P222T amino acid replacement in enzyme activity 
by molecular modeling the p.P222Q and p.P222T en-
zymes. To produce a three-dimensional model useful 
for interpreting biochemical data and for proposing and 
testing mechanisms of action for the 3b-HSD2 protein 
a model should be obtained based upon a protein with 
an already resolved crystallographic structure. To select 
such a model, one parameter was that the fold of the 
proteins should be similar enough so that energy of the 
model would be minimal (27-29). To establish simi-
larities among candidate sequences the blast algorithm 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi) was used. 
The three-dimensional structure of human type 1 3b-
HSD/isomerase was modeled before using the crystal 
structure of UDP-galactose 4-epimerase from E. coli as 
template, an enzyme with 30% overall sequence identity 
(30). Here we tested the vestitone reductase sequence 
from Medicago sativa L. as template for a model of hu-
man type 2 3b-HSD/isomerase to analyze the effect of 
mutations in the protein sequence.
The consequence of amino acid replacement on 
3b-HSD2 activity can be inferred according to the bio-
chemical properties of each amino acid. Proline has a 
non-polar side-chain and is hydrophobic, tending to 
cluster with other hydrophobic residues on the inside 
of the protein. In addition, proline is a rigid amino acid 
due to the covalent binding of its side-chain with the 
nitrogen main-chain. As a consequence of this unique 
cyclic side-chain, proline has a significant effect upon 
the geometry of the backbone chain and also disrupts 
any regular repeating structure of the three-dimension-
al conformation of polypeptides. Indeed, proline can 
act as a structural disruptor for α-helices and as a turn-
ing point in b-sheets. As observed in figure 2B, residue 
Pro222 in the 3b-HSD2 enzyme is located on the edge 
between an α-helice and a b-sheet. When changed to 
glutamine or threonine the b-sheet is mantained show-
ing that both variations impose on the protein a drastic 
conformational change in this region. Both glutamine 
and threonine have uncharged polar side-chains and are 
hydrophilic residues, clustering on the outside of pro-
teins. The distinct biochemical properties of proline, 
Structural aspects of HSD3B2 gene mutations
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glutamine, and threonine dictate the putative interac-
tions of these amino acids with other surrounding resi-
dues, as summarized in figure 2C.
The mutant residues Q222 and T222 suppress hy-
drophobic interaction with V220, normally observed 
for P222. As those differences in the structure of resi-
due 222 can affect other regions of the protein, analy-
sis of the substrate-binding and membrane-spanning 
domains was performed (2,26). No change in the 
membrane-spanning domain (data not shown) was 
observed. However, modifications in one substrate-
binding region were observed. The 251-274 domain 
in Q222 and T222 mutant protein presents a b-sheet 
conformation, while the wild-type has a flexible turn 
(Figure 3). Considering that 3b-HSD2 enzyme con-
tains only two substrate-binding regions, residues 176-
186 and 251-274 (26), this result suggests that reduc-
tion in protein activity is mainly due to an impairment 
of substrate binding. Finally, the native residue P222 
appears to be essential for the hydrophobic surfaces 
on that particular position of the enzyme. Moreover, 
it seems to establish specific residue interactions that 
must be critical for the 3b-HSD2 enzyme to achieve 
the appropriate conformation for its catalytic activity. 
In summary, this study has provided further in-
sight concerning the structure-function relationship of 
3b-HSD2 mutants. Molecular homology modeling of 
the mutant 3b-HSD2 showed potential roles for mutat-
ed residues. These findings have emphasized codon 222 
as an important residue for catalytic activity of the en-
zyme and allowed us to correlate with biochemical data 
previously reported (23). Moreover, it can be concluded 
that structural analysis provides additional insight to the 
understanding of enzyme action and consequently, it is 
an important tool for genotype-phenotype correlation. 
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